Discover 7 powerful signs your liver is healing after you stop drinking alcohol, from improved energy to better digestion and ...

GSK will buy efimosfermin, a liver disease drug in late-stage trials, for up to $2 billion from U.S. biotechnology firm ...

Alcohol consumption poses a significant global health risk, contributing to numerous diseases and injuries, especially among ...

Poor diet, sedentary lifestyle, and metabolic issues like obesity and insulin resistance often result in fatty liver disease ...

Discover a study that has proposed a predictive model for cirrhosis and hepatocellular carcinoma in individuals with ...

A new study suggests that semaglutide, the active ingredient in Ozempic, may help decrease liver fat, inflammation, and ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

Females with AUD are different than men with AUD, but most treatments were tested on men. Researchers are now looking at why ...

GSK has agreed to pay $1.2 billion upfront to acquire rights to efimosfermin from Cambridge, Massachusetts-based Boston ...